Trial Profile
Postmarketing Study Of Lybrel In Relation To Venous Thromboembolism.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary) ; Ethinylestradiol; Ethinylestradiol/norethisterone; Oral contraceptives
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors Pfizer
- 25 Jul 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 01 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2011 New trial record